Steven A. Kaplan

8.7k total citations · 2 hit papers
142 papers, 6.4k citations indexed

About

Steven A. Kaplan is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steven A. Kaplan has authored 142 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Urology, 81 papers in Rheumatology and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steven A. Kaplan's work include Urinary Bladder and Prostate Research (114 papers), Pelvic floor disorders treatments (72 papers) and Prostate Cancer Diagnosis and Treatment (49 papers). Steven A. Kaplan is often cited by papers focused on Urinary Bladder and Prostate Research (114 papers), Pelvic floor disorders treatments (72 papers) and Prostate Cancer Diagnosis and Treatment (49 papers). Steven A. Kaplan collaborates with scholars based in United States, United Kingdom and Canada. Steven A. Kaplan's co-authors include Alexis E. Te, Zoë Kopp, Karin S. Coyne, Claus G. Roehrborn, Christopher Sexton, Lalitha P. Aiyer, Ricardo R. González, Christopher R. Chapple, Ian Milsom and Jaspreet S. Sandhu and has published in prestigious journals such as The Journal of Urology, European Urology and Foreign Affairs.

In The Last Decade

Steven A. Kaplan

139 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

2009 562 citations Steven A. Kaplan et al. profile →
Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement

2010 459 citations Steven A. Kaplan et al. European Urology profile →

Peers

Countries citing papers authored by Steven A. Kaplan

Since Specialization

Citations

This map shows the geographic impact of Steven A. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Kaplan more than expected).

Fields of papers citing papers by Steven A. Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Kaplan. The network helps show where Steven A. Kaplan may publish in the future.

Co-authorship network of co-authors of Steven A. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Kaplan. A scholar is included among the top collaborators of Steven A. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Kaplan. Steven A. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women 2016 ·Post Reproductive Health ·Bilal Chughtai, James Forde, (unknown), (unknown), Richard Lee, Alexis E. Te, Steven A. Kaplan	19
2	Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women. 2015 ·PubMed Central ·Bilal Chughtai, Leanna Laor, (unknown), Richard K. Lee, Alexis E. Te, Steven A. Kaplan	7
3	Do Patient Characteristics Predict Responsiveness to Treatment of Overactive Bladder With Antimuscarinic Agents? 2014 ·Urology ·Sender Herschorn, Steven A. Kaplan, Franklin Sun, Fady Ntanios	16
4	One-Arm, Open-Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Scale-Up of Nonsurgical Circumcision When Performed by Nurses in Resource-Limited Settings for HIV Prevention 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Vincent Mutabazi, Steven A. Kaplan, Emile Rwamasirabo, (unknown), (unknown), (unknown), Corine Karema, Agnès Binagwaho	35
5	Tolterodine for the treatment of urge urinary incontinence 2013 ·Expert Opinion on Pharmacotherapy ·Dean Elterman, Bilal Chughtai, Steven A. Kaplan, Jack Barkin	5
6	PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 2013 ·Current Bladder Dysfunction Reports ·Mauro Gacci, Arcangelo Sebastianelli, Matteo Salvi, Linda Vignozzi, Giovanni Corona, Kevin T. McVary, Steven A. Kaplan, Matthias Oelke, Mario Maggi, Marco Carini	13
7	The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction 2013 ·Research and Reports in Urology ·Mauro Gacci, Matteo Salvi, Arcangelo Sebastianelli, Linda Vignozzi, (unknown), Kevin T. McVary, Steven A. Kaplan, Mario Maggi, Marco Carini, (unknown)	16
8	Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder 2012 ·Journal of Medical Economics ·(unknown), Richard K. Lee, (unknown), M. Treur, Marc Botteman, Steven A. Kaplan, Jeffrey Trocio	7
9	Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial 2012 ·European Urology ·Steven A. Kaplan, Weizhong He, William Koltun, (unknown), Tim Schneider, Allam Fakhoury	67
10	Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams 2010 ·Urology ·Doreen E. Chung, Alexis E. Te, David Staskin, Steven A. Kaplan	32
11	Fifth Joint Meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological Association 2010 ·International Journal of Urology ·Robert P. Myers, Narihito Seki, Momokazu Gotoh, Toby C. Chai, Steven A. Kaplan, Keiji Inoue, John Trachtenberg, Eiji Kikuchi, (unknown), Sam S. Chang, Cheryl Lee, Satoru Muto, Kazuto Ito, Gerald L. Andriole, Masatoshi Eto, Makoto Sumitomo, Tomomi Kamba, (unknown), Vitaly Margulis, Seiji Naito, Shin Egawa	1
12	Voiding dysfunction in men: pathophysiology and risk factors 2008 ·International Journal of Impotence Research ·(unknown), Steven A. Kaplan	7
13	Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size 2008 ·European Urology ·Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan	59
14	Long-Term Treatment With Finasteride Results in a Clinically Significant Reduction in Total Prostate Volume Compared to Placebo Over the Full Range of Baseline Prostate Sizes in Men Enrolled in the MTOPS Trial 2008 ·The Journal of Urology ·Steven A. Kaplan, Claus G. Roehrborn, John D. McConnell, Alan G. Meehan, (unknown), Jeannette Y. Lee, J. Rotonda, John W. Kusek, Leroy M. Nyberg	63
15	Identification of the patient with enlarged prostate: diagnosis and guidelines for management 2007 ·PubMed ·Steven A. Kaplan	4
16	5α-reductase inhibitors: what role should they play? 2001 ·Urology ·Steven A. Kaplan	28
17	Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride 2000 ·Urology ·Steven A. Kaplan, (unknown), Patricia Gilhooly, (unknown), Richard F. Labasky, (unknown), Pratap Reddy, Steven Rosenberg, David Sussman, C Michael White, Michael Lee, Frances Pappas, Joanne Waldstreicher	46
18	EFFECT OF DOXAZOSIN ON THE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA: RESULTS FROM THREE DOUBLE‐BLIND PLACEBO‐CONTROLLED STUDIES 1997 ·International Journal of Clinical Practice ·(unknown), Steven A. Kaplan, Kathleen Ice, Michael Gaffney, (unknown)	15
19	Transurethral electrovaporization of bladder cancer 1996 ·Urology ·James M. McKiernan, Steven A. Kaplan, Richard P. Santarosa, Alexis E. Te, Ihor S. Sawczuk	11
20	The North American experience with the urolume endoprosthesis as a treatment for benign prostatic hyperplasia: Long-term results 1994 ·Urology ·Joseph E. Oesterling, Alfred J. Defalco, Steven A. Kaplan, Pratap K. Reddy, Howard E. Epstein, Michael B. Chancellor	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact